Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 3
1985 5
1986 6
1987 30
1988 14
1989 13
1990 36
1991 20
1992 60
1993 40
1994 26
1995 22
1996 55
1997 67
1998 87
1999 92
2000 127
2001 167
2002 148
2003 157
2004 184
2005 175
2006 177
2007 188
2008 161
2009 142
2010 161
2011 139
2012 170
2013 192
2014 153
2015 178
2016 178
2017 161
2018 176
2019 175
2020 154
2021 165
2022 164
2023 180
2024 161
2025 175
2026 98

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,551 results

Results by year

Filters applied: . Clear all
Page 1
Carvedilol.
Beattie K, Phadke G, Novakovic J. Beattie K, et al. Profiles Drug Subst Excip Relat Methodol. 2013;38:113-57. doi: 10.1016/B978-0-12-407691-4.00004-6. Profiles Drug Subst Excip Relat Methodol. 2013. PMID: 23668404 Review.
A profile of this drug substance is provided in this chapter and includes physical characteristics of Carvedilol (e.g., UV-vis, IR, NMR, and mass spectra). Details regarding the stability of Carvedilol in the solid state and solution phase are presented and methods …
A profile of this drug substance is provided in this chapter and includes physical characteristics of Carvedilol (e.g., UV-vis, IR, N …
How Carvedilol activates beta(2)-adrenoceptors.
Benkel T, Zimmermann M, Zeiner J, Bravo S, Merten N, Lim VJY, Matthees ESF, Drube J, Miess-Tanneberg E, Malan D, Szpakowska M, Monteleone S, Grimes J, Koszegi Z, Lanoiselée Y, O'Brien S, Pavlaki N, Dobberstein N, Inoue A, Nikolaev V, Calebiro D, Chevigné A, Sasse P, Schulz S, Hoffmann C, Kolb P, Waldhoer M, Simon K, Gomeza J, Kostenis E. Benkel T, et al. Nat Commun. 2022 Nov 19;13(1):7109. doi: 10.1038/s41467-022-34765-w. Nat Commun. 2022. PMID: 36402762 Free PMC article.
Carvedilol is among the most effective beta-blockers for improving survival after myocardial infarction. ...Here, we offer an alternative mechanism to rationalize carvedilol's cellular signalling. Using primary and immortalized cells genome-edited by CRISPR/C …
Carvedilol is among the most effective beta-blockers for improving survival after myocardial infarction. ...Here, we offer an alterna …
Carvedilol.
[No authors listed] [No authors listed] Can Fam Physician. 1999 May;45:1199-202, 1205-9. Can Fam Physician. 1999. PMID: 10349064 Free PMC article. Clinical Trial.
Carvedilol is the first beta-blocker to obtain approval for treatment of heart failure. Improvement in hemodynamic parameters was initially documented in three methodologically sound studies involving 156 patients. ...When treatment is introduced very gradually, adverse ef …
Carvedilol is the first beta-blocker to obtain approval for treatment of heart failure. Improvement in hemodynamic parameters was ini …
The pharmacology of carvedilol.
Ruffolo RR Jr, Gellai M, Hieble JP, Willette RN, Nichols AJ. Ruffolo RR Jr, et al. Eur J Clin Pharmacol. 1990;38 Suppl 2:S82-8. doi: 10.1007/BF01409471. Eur J Clin Pharmacol. 1990. PMID: 1974511 Review.
Carvedilol is also a potent alpha 1-adrenoceptor antagonist (KB = 11 nM), which accounts for most, if not all, of the vasodilating response produced by the compound. ...The data indicate that carvedilol is an antihypertensive agent that is both a beta-adrenoceptor a …
Carvedilol is also a potent alpha 1-adrenoceptor antagonist (KB = 11 nM), which accounts for most, if not all, of the vasodilating re …
Carvedilol sensitizes chemotherapy by targeting STING to boost anti-tumor immunity.
Dang Y, Ma M, Wang Y, Zhao M, Cao Y, Su H, Liu T, Zheng M, Gao J, Wu X, Xu J, Chen L, Xi JJ, Fei Y, Liu H. Dang Y, et al. Cell Rep. 2025 May 27;44(5):115572. doi: 10.1016/j.celrep.2025.115572. Epub 2025 Apr 17. Cell Rep. 2025. PMID: 40249703 Free article.
Mechanistically, carvedilol interacts with STING at threonine 263 and enhances its dimerization. Importantly, carvedilol enhances the therapeutic effect of etoposide in both the allografted tumor model and patient-derived tumor-like cell clusters (PTCs) by promoting …
Mechanistically, carvedilol interacts with STING at threonine 263 and enhances its dimerization. Importantly, carvedilol enhan …
Assuming the worst may not be bad at all. Carvedilol in heart failure treatment.
Schmidt BM, Janson CP, Wehling M. Schmidt BM, et al. Eur J Clin Pharmacol. 1998 Jun;54(4):281-5. doi: 10.1007/s002280050460. Eur J Clin Pharmacol. 1998. PMID: 9696950
The aim of this meta-analysis is to review the data on mortality from two large study programs (the US Carvedilol Heart Failure Study and the study by the Australia/New Zealand Heart Failure Research Collaborative Group) on additional carvedilol treatment in CHF sta …
The aim of this meta-analysis is to review the data on mortality from two large study programs (the US Carvedilol Heart Failure Study …
Aging, cardiotoxicity, and chemotherapy.
Bocchi EA, Avila MS, Ayub-Ferreira SM. Bocchi EA, et al. Aging (Albany NY). 2019 Jan 22;11(2):295-296. doi: 10.18632/aging.101776. Aging (Albany NY). 2019. PMID: 30668542 Free PMC article. No abstract available.
Meta-analysis of the effects of carvedilol versus metoprolol on all-cause mortality and hospitalizations in patients with heart failure.
Briasoulis A, Palla M, Afonso L. Briasoulis A, et al. Am J Cardiol. 2015 Apr 15;115(8):1111-5. doi: 10.1016/j.amjcard.2015.01.545. Epub 2015 Jan 31. Am J Cardiol. 2015. PMID: 25708861 Review.
It remains unclear if the beta blockers used in patients with HFrEF are equal or carvedilol is superior to metoprolol types. We performed a meta-analysis of the comparative effects of carvedilol versus metoprolol tartrate and succinate on all-cause mortality and/or …
It remains unclear if the beta blockers used in patients with HFrEF are equal or carvedilol is superior to metoprolol types. We perfo …
S- and R-Carvedilol Prevent Benzo(a)pyrene-Induced Lung Carcinogenesis.
Shahid A, Yeung S, Andresen BT, Huang Y. Shahid A, et al. Thorac Cancer. 2025 Jun;16(12):e70109. doi: 10.1111/1759-7714.70109. Thorac Cancer. 2025. PMID: 40534194 Free PMC article.
Lung cancer is the most common and deadly type of cancer. Our previous study showed that carvedilol, a beta-blocker, can prevent lung cancer induced by benzo(a)pyrene [B(a)P]. Carvedilol is a 1:1 racemic mixture of S- and R-carvedilol, with S-carved …
Lung cancer is the most common and deadly type of cancer. Our previous study showed that carvedilol, a beta-blocker, can prevent lung …
Tip loaded cyclodextrin-carvedilol complexes microarray patches.
Anjani QK, Sabri AHB, Hamid KA, Moreno-Castellanos N, Li H, Donnelly RF. Anjani QK, et al. Carbohydr Polym. 2023 Nov 15;320:121194. doi: 10.1016/j.carbpol.2023.121194. Epub 2023 Jul 11. Carbohydr Polym. 2023. PMID: 37659788 Free article.
Carvedilol, a beta-blocker prescribed for chronic heart failure, suffers from poor bioavailability and rapid first pass metabolism when administered orally. ...These findings suggest that the carvedilol-loaded dissolving MAPs have the potential to revolutionise the …
Carvedilol, a beta-blocker prescribed for chronic heart failure, suffers from poor bioavailability and rapid first pass metabolism wh …
4,551 results